W

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Business Management
Share
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.

Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

The bull market’s biggest enemy right now could be Bessent’s interventions

A stronger yen and higher Treasury yields could become a toxic combination for the bull market in stocks. Source：MarketWatch

DoubleZero adds Kalshi election market data ahead of US midterms

The expansion gives institutional and automated traders realtime access to Kalshi’s political markets as election betting activity continues to grow.…

Canadian whisky on the rocks? Crown Royal is set to avoid Trump’s new ban.

Canada’s top liquor brand looks on track for a reprieve because it’s bottled in the U.S. for American customers. Source：MarketWatch

Consensys to split into MetaMask and institutional blockchain company

The restructuring will separate MetaMask’s consumer business from Consensys’ Ethereum protocols and institutional blockchain infrastructure operations.…

Source：https://www.marketwatch.com/story/eli-lilly-is-suing-pharmacies-and-peptide-vendors-over-sales-of-the-next-big-weight-loss-drug-retatrutide-22434cce